T2 Biosystems to Participate in the H.C. Wainwright 26th Annual Global Investment Conference

Rhea-AI Summary

T2 Biosystems (NASDAQ:TTOO), a leader in rapid sepsis detection, announced its participation in the H.C. Wainwright 26th Annual Global Investment Conference. The company's management will host one-on-one meetings on September 11, 2024. Investors can access a virtual presentation on-demand through T2 Biosystems' website starting September 9, 2024, at 7:00 am ET.

This conference participation highlights T2 Biosystems' commitment to engaging with investors and showcasing its innovative technology in sepsis detection. The company's presence at this global investment event could potentially impact its stock performance and investor relations.

LEXINGTON, Mass., Aug. 27, 2024 (GLOBE NEWSWIRE) -- T2 Biosystems, Inc. (NASDAQ:TTOO), a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, today announced plans to participate in the upcoming H.C. Wainwright 26th Annual Global Investment Conference.

Management will host 1x1 meetings on Wednesday, September 11, 2024. Interested parties may access management’s corresponding virtual presentation on-demand on the “Investors” section of the Company’s website at www.t2biosystems.com beginning at 7:00 am ET on Monday, September 9, 2024.

About T2 Biosystems
T2 Biosystems, a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes, is dedicated to improving patient care and reducing the cost of care by helping clinicians effectively treat patients faster than ever before. T2 Biosystems’ products include the T2Dx^® Instrument, the T2Bacteria^® Panel, the T2Candida^® Panel, the T2Resistance^® Panel, and the T2Biothreat™ Panel, and are powered by the proprietary T2 Magnetic Resonance (T2MR^®) technology. T2 Biosystems has an active pipeline of future products, including the U.S. T2Resistance Panel, the Candida auris test, and the T2Lyme™ Panel. For more information, please visit www.t2biosystems.com.

Investor Contact:
Philip Trip Taylor, Gilmartin Group
philip@gilmartinIR.com
415-937-5406

FAQ

When is T2 Biosystems (TTOO) participating in the H.C. Wainwright Global Investment Conference?

T2 Biosystems (TTOO) will participate in the H.C. Wainwright 26th Annual Global Investment Conference on September 11, 2024, hosting one-on-one meetings.

How can investors access T2 Biosystems' (TTOO) presentation for the H.C. Wainwright conference?

Investors can access T2 Biosystems' (TTOO) virtual presentation on-demand through the 'Investors' section of the company's website at www.t2biosystems.com, starting September 9, 2024, at 7:00 am ET.

What is T2 Biosystems' (TTOO) main focus in the medical field?

T2 Biosystems (TTOO) is a leader in the rapid detection of sepsis-causing pathogens and antibiotic resistance genes.

Where is T2 Biosystems (TTOO) headquartered?

T2 Biosystems (TTOO) is headquartered in Lexington, Massachusetts.